Mbx Biosciences, Inc. · NASDAQ:MBX

Paradigm Biocapital Advisors LP reported a 5.20% stake in Mbx Biosciences, Inc. (Schedule 13G)

Event Jun 16, 2026 · Filed Jun 24, 2026

Paradigm Biocapital Advisors LP reported a 5.20% stake in Mbx Biosciences, Inc., 2,493,015 shares, as a passive investor on Jun 16, 2026. Filed Jun 24, 2026 (Schedule 13G).

Stake
5.20%
Shares
2,493,015
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Paradigm BioCapital Advisors LP5.20%2,493,015
Paradigm BioCapital Advisors GP LLC5.20%2,493,015
Senai Asefaw, M.D.5.20%2,493,015
Paradigm BioCapital International Fund Ltd.4.60%2,187,207

Source

View original at SEC

Related